Condition
Neurocognitive Disorders, Mild
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07279714Phase 2Recruiting
Fisetin in Mild Alzheimer's Disease
NCT07237009RecruitingPrimary
Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
NCT05457725Not ApplicableRecruiting
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
Showing all 3 trials